PROPER Act of 2018
USA115th CongressHR-5775| House
| Updated: 6/20/2018
Erik Paulsen
Republican Representative
Minnesota
Cosponsors (5)
Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018 (Sec. 2) This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period). (Sec. 3) The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs. (Sec. 4) The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Placed on the Union Calendar, Calendar No. 594.
Committee on Energy and Commerce discharged.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.
Mr. Curbelo (FL) moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5256-5258)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5775.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5256-5257)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5256-5257)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Health
Administrative law and regulatory proceduresAlternative treatmentsConsumer affairsDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesGovernment information and archivesHealth care costs and insuranceHealth care qualityHealth information and medical recordsHealth personnelHome and outpatient careHospital careMedicarePrescription drugsSolid waste and recycling
PROPER Act of 2018
USA115th CongressHR-5775| House
| Updated: 6/20/2018
Providing Reliable Options for Patients and Educational Resources Act of 2018 or the PROPER Act of 2018 (Sec. 2) This bill requires Medicare and Medicare Advantage (MA) prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the risks of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period). (Sec. 3) The bill also requires Medicare medication therapy management programs and MA in-home health risk assessments to include information about the safe disposal of prescription drugs. (Sec. 4) The bill prohibits inclusion of pain management questions in certain health care system surveys, unless the questions address the risks of opioid use and the availability of non-opioid alternatives.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ordered to be Reported (Amended) by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Placed on the Union Calendar, Calendar No. 594.
Committee on Energy and Commerce discharged.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-763, Part I.
Mr. Curbelo (FL) moved to suspend the rules and pass the bill, as amended.
Considered under suspension of the rules. (consideration: CR H5256-5258)
DEBATE - The House proceeded with forty minutes of debate on H.R. 5775.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5256-5257)
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5256-5257)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Finance.
Erik Paulsen
Republican Representative
Minnesota
Cosponsors (5)
Ways and Means Committee, Finance Committee, Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- HR 115-5714: To amend title XVIII of the Social Security Act to require Medicare Advantage plans offered under part C of the Medicare program and prescription drug plans offered under part D of such program to provide information relating to the safe disposal of prescription drugs that are controlled substances to certain individuals enrolled under such plans.
- HR 115-6: SUPPORT for Patients and Communities Act
- HR 115-5686: Medicare CHOICE Act of 2018
- HR 115-5719: To amend title XVIII of the Social Security Act to revise certain measures used under the Hospital Consumer Assessment of Healthcare Providers and Systems survey relating to pain management.
- S 115-3489: A bill to amend title XVIII of the Social Security Act to require Medicare Advantage plans offered under part C of the Medicare program and prescription drug plans offered under part D of such program to provide information relating to the safe disposal of prescription drugs that are controlled substances to certain individuals enrolled under such plans.
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresAlternative treatmentsConsumer affairsDepartment of Health and Human ServicesDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesGovernment information and archivesHealth care costs and insuranceHealth care qualityHealth information and medical recordsHealth personnelHome and outpatient careHospital careMedicarePrescription drugsSolid waste and recycling